NCT04457141

Brief Summary

JUSTIFICATION: Urinary incontinence is highly prevalent among women who play high impact sports such as running. that observed one of the possible reasons for this high prevalence is delayed activation of the pelvic floor in relation to the abdominal muscles. The use of minimalist shoes during the race produces changes in muscle and joint biomechanics and efficiency in the race. However, to date no studies evaluating the influence of footwear in the musculature of the pelvic floor during the race. OBJECTIVE: Describe and compare the electromyographic activity of the muscles of the pelvic floor and abdominal during the race with conventional shoes and minimalist. DESIGN: cross-over study experimental, analytical and prospective. METHODOLOGY: conventional and minimalist: 50 healthy young women, 6- randomly distributed in two groups will be included to characterise the electromyographic activity of the pelvic floor muscles before and during running at 6-9-11 km/h with the two types of running shoes. A baseline assessment will be performed to confirm that the women meet the inclusion and exclusion criteria. The ability to run a 10-minute treadmill at a speed of 6-9-11 km/h will be assessed, as well as the ability to adequately contract the pelvic floor muscles. The group of 50 women will initially run randomly with conventional running shoes or with minimalist running shoes, and then, after a 10-minute washout period, will run with the other type of running shoe, i.e. if a participant in the first phase used conventional running shoes, she will run with a minimalist running shoe in the second phase. The cadence of step, the range of movement of the femur and the EMG recording with electromyographic sensors of the pelvic floor musculature (using an intravaginal probe of the germproof brand), abdominal (internal and external oblique), spinal erectors and gluteus (using a surface sensor) in relation to the cycling gait will be collected and recorded with barographic sensors. The variables to be included in the electromyography for each muscle in relation to the gait cycle will be: onset of activation, duration, intensity and synergy with their corresponding standard deviation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

June 3, 2022

Status Verified

November 1, 2021

Enrollment Period

1.1 years

First QC Date

May 12, 2020

Last Update Submit

May 31, 2022

Conditions

Keywords

Pelvic floorElectromyographyBarefoot

Outcome Measures

Primary Outcomes (1)

  • Electrical activation of the pelvic floor musculature, abdominal, gluteus maximus and lumbar erectors during the race in nulliparous women with sneakers traditional and minimalist

    PeriformTM vaginal probe Will collect the EMG activity of the muscles of the pelvic also register with superficial electrodes EMG abdominal, gluteus maximus and lumbar erectors. Records are made in a single session with washout periods in accordance with previous studies that have collected the activity of the EMG activity PF during treadmill running different speeds.

    Basal, 0.5, 1.0, 1.5 minutes after the start of the test.

Secondary Outcomes (2)

  • Cadence and Range of motion in the sagittal plane of the femur during running at different speeds in nulliparous women with conventional and minimalist shoes.

    Basal, 0.5, 1.0, 1.5 minutes after the start of the test.

  • Maximum voluntary contraction (MVIC), minimum peak, maximum peak and total average of the muscles of the sp, abdominal (LE), gluteus maximus and erectors during running at different speeds in nulliparous women with conventional shoes and minimalist

    Basal, 0.5, 1.0, 1.5 minutes after the start of the test.

Study Arms (2)

first:shod ,second:minimalist shoes

OTHER

The first group will race with conventional shoes and then minimalist shoes. The group run 5 minutes for warming and then 30 seconds at 6km/h, 30 seconds at 9 km/h and 30 seconds at 11km/h. They have a washout period of 10 minutes between both interventions.

Combination Product: Effect of pelvic floor for the use of minimalist shoes versus shod in woman.

first:minimalist shoes ,second:shod

OTHER

The second group will race with minimalist shoes and then conventional shoes. The group run 5 minutes for warming and then 30 seconds at 6km/h, 30 seconds at 9km/h and 30 seconds at 11km/h. They have a washout period of 10 minutes between both interventions.

Combination Product: Effect of pelvic floor for the use of minimalist shoes versus shod in woman.

Interventions

Measure the activity of the pelvic floor and others muscles with EMG during treadmill running with different speeds and different shoes: minimalist and shod.

first:minimalist shoes ,second:shodfirst:shod ,second:minimalist shoes

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18 to 38 years.
  • Nulliparous.
  • Clinically healthy at the time of the study.
  • Physically able for the requirement of the race on tape.
  • Body Mass Index (BMI) 20-25 kg / m2
  • Having signed the informed consent.

You may not qualify if:

  • Pregnant women.
  • urogynecological dysfunction.
  • Lower limb surgeries performed in the last six months.
  • Not be able to make voluntary contractions of the pelvic floor standardized according to the Modified Oxford Scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Radiology, Rehabilitation and Physiotherapy

Madrid, 28040, Spain

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Maria Garcia

    universidad complutense

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: randomized clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2020

First Posted

July 7, 2020

Study Start

February 1, 2021

Primary Completion

March 1, 2022

Study Completion

April 1, 2022

Last Updated

June 3, 2022

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

All the researchers will participate in all the study phases.

Locations